APA (7th ed.) Citation

Wu, H., Wang, P., Chen, Y., & Chao, W. (2025). Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study. Elsevier.

Chicago Style (17th ed.) Citation

Wu, Hua-Hsi, Peng-Hui Wang, Yi-Jen Chen, and Wei-Ting Chao. Efficacy and Safety of Oxaliplatin-based Hyperthermic Intraperitoneal Chemotherapy with Secondary Cytoreduction for Platinum Resistant Recurrent Ovarian Cancer: A Single-center Retrospective Cohort Study. Elsevier, 2025.

MLA (9th ed.) Citation

Wu, Hua-Hsi, et al. Efficacy and Safety of Oxaliplatin-based Hyperthermic Intraperitoneal Chemotherapy with Secondary Cytoreduction for Platinum Resistant Recurrent Ovarian Cancer: A Single-center Retrospective Cohort Study. Elsevier, 2025.